Dr. Maillard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-615-0063Fax+1 215-349-8144
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2005
- University of Lausanne Faculty of MedicineClass of 1993
Certifications & Licensure
- NY State Medical License 2024 - 2026
- PA State Medical License 2001 - 2024
- MI State Medical License 2007 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2024-12-26 - Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs.Anneka Allman, Brian T Gaudette, Samantha Kelly, Nagham Alouche, Léolène J Carrington
Immunity. 2024-12-25 - 1 citationsCondensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression.Yiman Liu, Qinglan Li, Lele Song, Chujie Gong, Sylvia Tang
Cancer Discovery. 2024-08-02
Journal Articles
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersMatthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaDale L Bixby, Ivan P Maillard, Moshe Talpaz, Leukemia Research
- Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in MiceIvan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
- Join now to see all
Abstracts/Posters
- Dll1 and Dll4 Notch Ligands Prime T Cell Alloimmunity and Are Expressed in Non-Overlapping Populations of Fibroblastic Stromal Cells in Spleen and Lymph Nodes at the O...Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic TransformationIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Stromal Cell Immune Regulation in the Microenvironment61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaJune 2018
Press Mentions
- Genome Toxicity and Impaired Stem Cell Function After Conditional Activation of CreERT2 in the IntestineNovember 15th, 2018
- Antibody Prevents Gastrointestinal GVHD Without Broad ImmunosuppressionJuly 1st, 2023
- Three-Drug Regimen Improves Protection Against GVHD After Stem Cell TransplantJuly 18th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- French, German, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: